Lumira Ventures is a leading healthcare venture capital firm that operates actively in North America. With over two decades of experience and over $1 billion invested, Lumira Ventures is committed to making a significant impact in the healthcare industry. Their portfolio consists of more than 100 innovative healthcare companies, focusing on areas such as diabetes, Alzheimer's, vision loss, heart failure, asthma, infectious diseases, and other medical needs affecting over 1 billion people worldwide.

Lumira Ventures' investment strategy revolves around transformative healthcare products that offer substantial improvements in patient health outcomes while reducing healthcare costs. They are renowned for their Canadian heritage, which enables them to invest in cutting-edge medical science and clinical insights, shaping the future of patient care. What sets Lumira Ventures apart is their unique approach.

They invest in regions often overlooked by other venture capitalists, align the financial interests of fund investors, and provide entrepreneurs with invaluable support. With a stable team and global industry relationships, Lumira Ventures is dedicated to driving innovation and revolutionizing the healthcare landscape